This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Phillip Schwartz, Ph.D.
President of R&D and EVP at Entera Bio Ltd.

Profile

Phillip Schwartz , Ph.D., is the Founder and President of Entera Bio. Dr. Schwartz served as the CEO from 2010 till 2019 and is a member of the Board of Directors since 2010. Dr. Schwartz took Entera public on the NASDAQ in 2017 and executed a $270 million collaboration with Amgen in 2018. Prior to Entera Bio Dr. Schwartz held multiple positions at Serono and Endo Pharmaceuticals and has also served as a consultant to more than 20 large biotech and pharmaceutical companies and several venture capital firms. Dr. Schwartz received his Ph.D. in neurobiology/developmental oncology from Harvard Medical School and worked for 2+ years with Nobel Laureate Prof. Torsten Wiesel at the Rockefeller University.

Agenda Sessions

  • ROOM 205B: Oral Delivery of PTH 1-34 in the Treatment of Hypoparathyroidism and Osteoporosis

    11:45am

Speakers at this event